AE classification, reporting, documentation Flashcards

1
Q

Any untoward medical occurrence associated with the use of a drug in humans, whether or not considered drug related.

A

Adverse Event

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

An ____________ can be any unfavorable and unintended sign (e.g. an abnormal lab finding), symptom, or disease temporarily associated with the use of a drug, without any judgment about causality or relationship to the drug.

A

adverse event aka adverse experience

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Process of converting investigators’ “verbatim documentation” terms to standardized “preferred terms”

A

Coding of Adverse Events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Even if AEs are not related to or caused by the study drug, if they occur while the subject is on study, they must be collected and reviewed by the PI and tracked.
Examples include transfusion reactions, accidental injuries, surgery

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adverse Reaction

A

A suspected adverse reaction mean any adverse event for which there is a reasonable possibility that the drug caused the adverse event.
Reasonable possibility means ther eis evidence to suggest a causal relationship between teh drug and adverse event.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Serious Event or Serious Suspected Adverse Reaction

A

An adverse events or suspected aderse reaction is considered “serious” if, in the view of either the investigator or sponsor, it results in any of the following outcomes: death, life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization.
A persistent, or significant incapacity or substantial disruption of the ability to conduct normal life functions, or a congenital anomaly/birth defect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A “Life Threatening Adverse Drug Experience” Defined

A

Any adverse experience that places the subjec, in the view of the investigator, at immediate risk of death from the reaction as it occurred, or it is suspected that the use or continued use of the product would result in the patient’s death.
Examples: Hemorrhaging (bleed from ruptured blood vessel, especially when profuse) and internal bleeding with rapid drop in blood pressure, Loss of consciousness from increase in pressure on brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hospitalization

A

Admission to the hospital for longer than 24 hours or prolongation of hospital stay due to adverse event

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Disability

A

A substantial disruption of a person’s ability to conduct normal life functions.
Examples: loss of speech, fatigue so great the subject cannot get out of bed at all, loss of memory, paralysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Congenital Anomaly

A

Exposure to a medical product prior to conception or during pregnancy resulting in an adverse outcome in the child.
Example: Thalidomide - babies born with deformed arms and legs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Important medical events that may not result in death, be life threatening, or require hospitalization may be considered a ____________________ when, based upon appropriate medical judgment, they may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes listed in this definition

A

serious adverse drug experience

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The following are examples of _______________.
* Allergic bronchospasm requiring intentive treatment in an ER or at home
* blood dyscrasias - morbid general state, abnormal material in blood
* convulsions that do not result in inpatient hospitalization
* development of drug dependency or drug abuse

A

important medical events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Toxicities from the study drug are consdiered expected (vs unexpected) if found in…

A
  • safety info on approved products is reflected in product labeling (package insert)
  • up to date safety info on the products under investigation is found in the Investigator’s Brochure
  • from these sources the protocol and ICF is written to explain and describe what risks we currently expect from this study drug
  • safety profile of other drugs in this same class
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define an Unexpected Adverse Event

A

An adverse event or suspected adverse reaction is considered “unexpected” if it is not listed in the investigator brochure or is not listed at the specificity or severity that has been observed; or, if an investigator brochure is not required, available, is not consistent with the risk info described in the general investigational plan or elsewhere in the current application, as amended.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The following are examples of __________________.
* hepatic necrosis would be unexpected (by virtue of greater severity) if the investigator brochure only referred to elevated hepatic enzymes or helpatitis
* cerebral thromboembolism and cerebral vasculitis would be unexpected (by virtue of greater specificity) if the IB only listed cerebral vascular accidents

A

Unexpected Adverse Events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Severity (vs Serious)

A

Refers to the intensity of the event and can be used with any even without regard to whether or not it meets the federal criteria for “serious”… is expressed in ‘grades’ of severity

17
Q

It is the responsibility of the ___________ to concur with all intensity assessments added to the database for the events identified in the subject

A

Principal Investigator

18
Q

Grade 1

A

Asymptomatic or mild symptoms - clinical or diagnostic observations only - no intervention needed

19
Q

ADL

A

Activities of Daily Living

20
Q

Grade 2

A

Moderate
minimal, local, or noninvasive treatment indicated
limiting age-appropriate instrumental ADL

21
Q

Grade 3

A

Severe
Medical significant but not immeditely life-threatening
Hospitalization or prolongation of hospitalization indicated
Disabling
Limiting self care ADL

22
Q

Grade 4

A

Life threatening
Urgent intervention indicated.

23
Q

Grade 5

A

Death related to an AE

24
Q

IND

A

Investigational New Drug

25
Q

Coding of Adverse Events

A

Process of converting investigators’ “verbatim documentation” terms to standardized “preferred terms”